Good job penn33c, on calling the analyst. IDK about the 100 P/E thing. That's usually reserved for leaders in ultra high growth markets. So far, $ZYXI isn't bringing anything new to the market, just capitalizing an existing technology. This could change, however, when/if the blood volume monitor becomes a viable product. THAT'S where things could get interesting. That's one of the big reasons I'm here. ;)
UFO